Abstract
Introduction
The lack of exhaustive information on important protective antigens of Francisella tularensis is one important reason restricting the development of a new generation of tularemia vaccines. Until now, the nature of immunoprotection against tularemia still remains in dispute [l] . Among the most studied agents of F. tularensis are proteins of the outer membrane (OM) as they are known to crucially contribute to T-cell-mediated immunity . With regard to these proteins, no essential difference between tulurensis and palaearctica strains, including ' Corresponding author. Tel: + 7 (95) attenuated strains and avirulent capsule-free variants, has been detected. This finding questions the hypothesis that immunoprotection against tularemia solely depends on the immune response directed against proteins. The role of the lipopolysaccharide (LPS) in this regard is interesting. Purified LPS preparations of F. tularensis have not manifested toxic and protective properties typical for the endotoxin of other Gram-negative bacteria, but the protective effect against tularemia of monoclonal antibodies specific of O-side chain of LPS implies that LPS may be an important immunogen [9, 10] . Preparations of purified Francisella antigens such as the killed Foshay vaccine [I 11 have generally appeared to be ineffective in affording protective immunity in animals such as mice and guinea pigs. In Russia, guinea pigs are used as models to test the immunogenicity of live tularemia vaccines (LTV). Vaccines inoculated subcutaneously produce a manifested local reaction and 80-90% of the animals survive for at least a month after subcutaneous challenge with the virulent strain 503 (type B) in a dose of 1000 lethal doses (LD),,,,,.
The human immune response is closely related to the immune response of animals such as baboons [ 121, but not to that of guinea pigs and mice. The aim of this work is to study the immunogenic properties of OM-preparations of F. tularensis and to evaluate the main membrane antigens responsible for protection against tularemia. 
Materials and methods

Bacteria strains
Isolation of antigens
OM were obtained from bacterial cells inactivated with phenol [13] . Isolation of LPS-protein complexes and of the 17 kDa protein was accomplished by solubilisation of OM of F. tularensis with sodium desoxycholate and followed by gel-filtration on Sephacryl S-200 [ 141. LPS from virulent and vaccine strains (S-LPS) was obtained according to the method of Westphal [15] . LPS from R-variant of vaccine strain (R-LPS) was obtained by the method of Galanos [ 161.
Electron microscopy
Electron microscopy of OM was performed using Hitachi H-300 microscope (Japan). Preparations were contrasted with neutral solution of phosphotungstic acid. Ultrathin sections were prepared using LKB 8800-111 ultratome (Sweden) and contrasted with 1% solution of uranyl acetate. SDS-PAGE according to Laemmli [20] was performed using 8% and 12.5% gels stained with Coomassie brilliant blue or with silver ions [2 I] and by use of the Tsai staining [22] . Circular dichroism (CD) spectrum data were registered using Jasco-500A dichrograph (Japan), ultraviolet (UV) spectra (using Shim d a zu UV-2 100 spectrophotometer, Japan), infrared (IR) spectra (using Specord IR-71, Germany). The calculation of the secondary structures in proteins was performed as described by the method of Bolotina [23] .
Analytic methods
Concentrations
Immunodetection qf LPS and qf antibodies
Serological activity of LPS was determined by ELISA [24] using mAb (monoclonal antibody) FB-1 lx specific to the O-chain of F. tularensis LPS [lo] . LPS separated in SDS-PAGE were transferred onto a nitrocellulose sheet [25] by Western blotting. Antibodies in serum of experimental animals were detected by an agglutination test (AT) or passive hemagglutination analysis (PHA).
Immunisation and challenge of animals
Studies of protective properties of OM were carried out in guinea pigs weighing 250-310 g and in clinically healthy hamadryads (baboons) of both sexes weighing 4-6 kg. Guinea pigs were immunised subcutaneously with OM preparations (0.5 ml) in a dose of 0.25-0.5 mg. Non-immunised animals were used as the controls. Two-day cultures of the virulent strain 503 or 144/713 in dose of 100 or 1000 cfu were used for the challenge of guinea pigs. Subcutaneous immunisation of hamadryads was performed into the upper third of the arm at a dose of 2.0 mg per animal in 0.5 ml of physiologic salt solution. Challenge of OM-immunised animals was Downloaded from https://academic.oup.com/femspd/article-abstract/13/3/227/437357 by guest on 03 April 2019 Table I Comparative ' cfu = colony forming units.
Time interval between immuniaation and challenge was 30 days.
The duration of the experiment after challenge was 35 days.
performed subcutaneously with strain Schu in a dose of 787 cfu. 30 days after immunisation. Protective efficacy was determined by the absence or presence of signs typical of infection in challenged animals [26] . Studies of morphological changes in infected organs and isolation of F. tulurensis from them (blood. lymphatic nodes. spleen, liver, lungs) were carried out on the 20th day post challenge. Protective properties of LPS-protein complexes from OM, of the 17 kDa protein, or of LPS were studied in CBA mice weighing 18-20 g. Antigen preparations of different concentrations were injected in animals intraperitoneally.
Animals injected with physiologic salt solution were used as controls. Twenty-one days after immunisation, the animals were challenged with a suspension of the two-day culture of the virulent strain 503 in a dose of 50-90 cfu. The animals were observed for a month after challenge.
Results and discussion
Compositiorl of outer membranes
Using electron microscopy OM preparations were found to be transparent structures of round or irregular shapes. They had a three-layer profile of ultrathin sections. Whole, or partly destroyed, cells were not observed. The OMs were found to contain 12-22% protein. 1.5-30s carbohydrates. and 40% lipids. The high LPS content in OM preparations was confirmed by isolation of the LPS according to the Westphal method [16] . The yield of LPS was 20-30% of the total dry weight of membranes. By silver-staining, the tularemic LPS was found to be distributed in SDS-PAGE as discrete bands characteristic of LPS of Gram-negative bacteria. The OM of F. tularensis was found by SDS-PAGE to contain 2.5 protein fractions with molecular masses (M,) ranging from IO-80 kDa. The major integral proteins were repre- Table 2 Protective sented by proteins of M, 47, 43, 17, and 12 kDa. The lack of a previously characterized major protein with M, of 63 kDa [2, 27] can be explained by the fact that the protein had been removed from membrane surfaces by washing.
Immunogenicity qf outer membranes
A single subcutaneous immunisation of guinea pigs with OM preparations obtained either from vaccine or virulent strains induced efficient immunity. as demonstrated by the survival of 60-100% of the animals for a month after subcutaneous challenge with virulent strains 503 or 144/713 in a dose of 1000 LD,,, (Tables 1 and 2 ). The level of specific protection achieved using different series of OM preparations was comparable to that induced by LTV (live tularemia vaccine). Antibody titers on day 10 showed a marginal rise in immunised animals (1:20-1:80), but increased two-fold from then until the 2 lst-30th day. The protective effect reached its maximum by the 15th-21st day after immunisation and was maintained on a high level for 6 months. In another experiment, challenge was done nine months after immunisation.
Fifty percent of the animals survived for a month after challenge of 1000 LD,,, of strain 44/713.
It was not possible to isolate F. tularensis from parenchymatous organs of OM-immunised animals that survived a year after the challenge.
Subcutaneous immunisation with the OM preparations from the vaccine strain 15 in a dose of 2.0 mg prevented development of clinical infection in 70% of hamadryads after subcutaneous challenge with F. tularensis strain Schu (Table 3) . Antibody titers as determined by AT and PHA were in OM-immunised animals within the lowest range of detection cl:80 for AT and 1:320 for PHA) and showed an insignificant rise by day 20 after the challenge with the virulent strain. All the non-immunised animals demonstrated hemagglutinating antibody-titers of 1: 1280 after challenge with strain Schu. Protection in these animals was defined as the absence of pathological changes typical of tularemia in internal organs and by the failure to cultivate F. tularensis from the same organs. However, some slight pathological changes in lungs and spleens were observed in one of six hamadryads after being immunised with OM and challenged with strain Schu. From this animal, F. tularensis could be isolated from internal organs. The five other animals showed no signs of infection. Collectively.
protection afforded by the 
Composition of LPS-protein complex
A number of LPS-protein complexes were obtained after separation of solubilised F. tularensis OM on S-200. A complex of particular interest contained proteins with M, of 17-19 kDa. According to IR-spectroscopy data, the LPS/protein ration in the complex was 1:l by mass. The CD-spectrum shape of the protein compound or the complex suggested an a-helical confirmation of protein.
Immunogenicity of LPS-protein complex
A single intraperitoneal immunisation of the LPS-protein complex in CBA mice afforded survival after a challenge of 50-90 cfu with strain 503. ED,, (the immunising dose of antigen that protects 50% of the animals) for the LPS-protein complex was 0.004-0.034 mg/animal (Table 4) . It had to be determined whether the 17 kDa protein free of LPS efficiently confers resistance against F. tularensis or if the mixture of both components is required to obtain the efficient protection.
One avirulent R-variant of the vaccine strains was used for isolation of the 17 kDa protein. Here, purification of protein free from S-LPS is accomplished, as there are essential differences between the LPS from S-culture due to the fact that the R-LPS, in contrast to S-LPS, has no specific O-side polysaccharide chains and the molecule only consists of lipid A and core sugars. The differences between LPS from S-and R-cultures were confirmed using monoclonal antibodies specific to the O-chain of LPS. The 17 kDa protein extinction coefficient at maximum absorption at 279 nm was 1.3 1 X g -' X sm '. As estimated from CD-spectrum, the content of the secondary structures in the 17 kDa protein molecule was 28% of cy-helices. 26% of P-sheets, and 46% of random conformation.
Immunisation of CBA mice with the purified S-LPS preparation in doses of 0.008-1 .O mg did not result in resistance to subcutaneous challenge of 500 LD,,,, of the virulent strain 503. Some animals survived after challenge with the virulent strain 503 in mice immunised with the 17 kDa protein. Simple mixtures of purified LPS from the virulent strain 503 and the 17 kDa protein from a avirulent R-bacteria resulted in a LPS-protein complex which upon immunisation afforded resistance against challenge with the virulent strain 503. The LPS-17 kDa protein complex gave a pronounced protective effect (EDSo = 0.038) at a 1:2 ratio by mass (Table 5) .
Discussion
A F. tularensis LPS-protein complex consisting of R-LPS and a 17 kDa protein of the OM is here shown to efficiently protect against virulent strains of F. tularensis. It is possible that efficient intracellular processing of antigens and macrophage presentation of epitopes in association with class II histocompatibility molecules are required to obtain protective immunity against F. tularensis. These conditions may be provided by the F. tularensis vaccine strains as they persist in immunised animals and in humans for a certain period of time. Thereby, the repeated stimulation of immune system leads to the development of protective immunity. After immunisation with killed cells or polycomponent antigens, the number of protective epitopes presented by macrophages may not be sufficient to efficiently compete with peptides containing non-protective epitopes, or peptides derived from other antigens. Therefore, a selection of antigens with protective properties is required to achieve efficient protection against F. tularensis. The acquisition of exhaustive information on important protective antigens of F. tularensis and further elucidation of specific immune mechanisms involved will form the basis in the development of a new generation of anti-tularemia vaccines.
